Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Aditxt (ADTX)

Aditxt Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADTX
DateTimeSourceHeadlineSymbolCompany
03/05/202419:14Business WireCORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
03/05/202414:00Business WireAditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
02/04/202413:30Business WireAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)NASDAQ:ADTXAditxt Inc
27/03/202412:36PR Newswire (US)Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023NASDAQ:ADTXAditxt Inc
11/03/202420:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/03/202412:54PR Newswire (US)For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended PregnancyNASDAQ:ADTXAditxt Inc
04/03/202422:27Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
04/03/202422:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
01/03/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
29/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
22/02/202422:21Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADTXAditxt Inc
21/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
16/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
15/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
14/02/202414:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADTXAditxt Inc
09/02/202421:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
06/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/02/202421:28Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
02/02/202421:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
01/02/202413:00PR Newswire (US)Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023NASDAQ:ADTXAditxt Inc
30/01/202422:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
30/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
30/01/202413:30Business WireAditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCapâ„¢ and NeuroEEGâ„¢ for Telehealth and Tele-neurology ApplicationsNASDAQ:ADTXAditxt Inc
23/01/202421:18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ADTXAditxt Inc
19/01/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
18/01/202421:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADTXAditxt Inc
09/01/202422:19Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
09/01/202422:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
08/01/202413:30Business WireAditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 MillionNASDAQ:ADTXAditxt Inc
05/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
 Showing the most relevant articles for your search:NASDAQ:ADTX